Purchase Order 75N98026P01528

This $11,033 firm-fixed-price purchase order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Bio-Techne Sales Corporation. The contract is for Luminex assays to measure 28 analytes in order to identify the role of soluble factors in patients with lymphangioleiomyomatosis (LAM). The order has a period of performance through November 18, 2025. Bio-Techne Sales Corporation is a for-profit organization that specializes in...

<p>The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a $25,000 purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. This firm fixed price contract runs from September 2022 through September 2023 and will provide unspecified products or services to support NIH Clinical Center programs. Bio-Techne will perform all work as the prime contractor. No subcontractors or additional context were provided regarding the award.</p>

This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to the vendor Proteinsimple (also known as Bio-Techne Corporation Division). The $12,075 contract is for the supply of a CUSTOM SIMPLE PLEX CARTRIDGE KIT FOR 32 SAMPLES, HUMAN in order to continue testing of leptin, growth hormone, BDNF, and insulin in goat protocol samples. There was no set-aside used for this award, which has a completion...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,672.20 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&amp;D Systems, a division of Bio-Techne Corporation. The contract is for the delivery of recombinant human NT-3 protein to support the agency's research efforts. As the prime contractor, R&amp;D Systems will provide the requested products from its...

The U.S. National Institutes of Health (NIH) Clinical Center awarded a $24,461.93 firm fixed price purchase order to Bio-Techne Sales Corporation, a for-profit provider of biological research products. The contract is for the delivery of Bio-Techne kits and materials, which are used to support various scientific and medical research programs at the NIH, including studies related to cancer, environmental health, substance abuse, and translational science. The period of performance runs through...

<p>The National Institutes of Health Clinical Center awarded a purchase order to Proteinsimple (Bio-Techne Sales Corporation) valued at $72,642.70 on September 4, 2026, for specialized protein analysis products and services. Work is performed in San Jose, California. The order is firm fixed price with an ultimate completion date of September 30, 2026.</p>

This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Health and Human Services' National Institutes of Health (NIH) Office of Logistics and Acquisition Operations to Peprotech Inc., a private biotechnology company. The contract has a ceiling value of $12,012.00 and a period of performance ending on May 31, 2011. Peprotech Inc. is providing biological materials, including recombinant cytokines and proteins, to support NIH's research efforts. This BPA...

<p>The National Institute on Aging awarded a purchase order to Peprotech Inc. for $9,470.00 on August 8, 2017, with completion by September 7, 2017. Performance occurs in Baltimore, Maryland. The order procures cytokine and protein products for research use under firm fixed-price terms with no set-aside designation.</p>

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,399.52 firm fixed price purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. Under this contract, Bio-Techne will provide fetal bovine serum to support the NIH National Cancer Institute's research efforts. The one year contract runs from July 20, 2023 through July 19, 2024 and was awarded without any set aside designations. Bio-Techne will serve as the prime...

<p>The NIH Clinical Center awarded a purchase order to Biolegend, Inc. for $16,488.00 on May 7, 2026, for TOTALSEQ-D Human Heme Oncology Cocktail biomedical reagents. No small business set-aside was applied. Work is performed in San Diego, California. The order carries a firm fixed price and is scheduled for completion by September 30, 2026.</p>